Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
基本信息
- 批准号:7589776
- 负责人:
- 金额:$ 26.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-21 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:A MouseAdenovirus VectorAmino AcidsApplications GrantsBindingBinding SitesBiological AssayBromodeoxyuridineCell Culture TechniquesCell CycleCellsCo-ImmunoprecipitationsCyclic AMPDNADNA Replication FactorDNA biosynthesisDataDevelopmental BiologyE2F1 geneEP300 geneExhibitsFastingGene ExpressionGene TargetingGenesGenetic TranscriptionGenomicsGrowthGrowth FactorHepaticHepatocarcinogenesisHepatocyteIn VitroInflammatoryInjuryLaboratoriesLicensingLicensing FactorLinkLiverLiver RegenerationMeasuresMediatingMetabolicMetabolismModelingModificationMolecularMusMutateNIH Program AnnouncementsNatural regenerationNaturePartial HepatectomyPhasePhase TransitionPhosphorylationPhysiologicalPrimary carcinoma of the liver cellsProteinsRecruitment ActivityRefractoryRegulationRelative (related person)Replication LicensingResearch PersonnelRoleSerumSignal TransductionSite-Directed MutagenesisStagingTestingTimeTranscription CoactivatorTranscriptional ActivationTranscriptional Regulationbasecdc Genesin vivoliver cell proliferationliver transplantationmRNA Expressionmutantprogramspromoterregenerativeresponsetherapeutic development
项目摘要
DESCRIPTION (provided by applicant): The ability of the liver to recover from toxic, infectious or inflammatory injury and following liver transplantation is due in large part to the ability of quiescent (GO), metabolically active hepatocytes to reenter the cell cycle en masse. Hepatocyte reentry into the cell cycle and genomic integrity are critically dependent on E2F regulated activation of DNA replication licensing factors. TGF-a induces hepatocyte proliferation in physiologic growth and in the preneoplastic stages of hepatocellular carcinoma. We have identified C/EBP¿ as a key transcriptional activator of E2F-regulated genes that control the licensing of DNA replication during hepatocyte proliferation. We have shown that induction of C/EBP¿-dependent induction of DNA replication factors is both stimulated by TGF-a and dependent on C/EBP¿ in primary hepatocytes. Recent evidence has identified an important link between the metabolic state and activation of cell cycle associated genes including those regulated by E2F factors. We have discovered that the potential coactivator PGC-1a, previously implicated in the response to fasting, is rapidly induced following partial hepatectomy in a C/EBP¿-dependent manner and is bound to the promoters of E2F regulated genes including several C/EBP¿ targets, suggesting that this coactivator is an important link between metabolic signals and hepatocyte proliferation. Based on data from our laboratory and others, we hypothesize that C/EBP¿ is a central integrator of growth factor and metabolic signals to hepatocytes. In Specific Aim 1, we will investigate the contribution of C/EBP¿ phosphorylation and C/EBP¿-E2F interactions for regulation of DNA licensing proteins during hepatocyte proliferation. In Specific Aim 2, we will investigate the mechanism for activation of PGC-1a by C/EBP¿. In Specific Aim 3, we will analyze the functional role of PGC-1a in hepatocyte proliferation in the regenerating liver. This grant application is directly responsive to Program announcement PA-06-231. "Developmental Biology and Regeneration of the Liver." Understanding the mechanisms underlying hepatocyte proliferation will inform the development of therapeutics to augment the regenerative capacity of the liver and will elucidate mechanisms of abnormal hepatocyte proliferation that occur during early stages of hepatocellular carcinogenesis.
描述(由适用提供):肝脏从有毒,传染性或炎症性损伤以及肝移植后恢复的能力很大程度上归功于静态(GO)(GO),代谢活性的肝细胞能够重新进入细胞周期。肝细胞重新进入细胞周期,基因组完整性严重取决于E2F调节的DNA复制许可因子的激活。 TGF-A诱导肝细胞增殖在生理生长和肝细胞癌的肿瘤阶段。我们已经确定C/EBP¿是控制肝细胞增殖期间DNA复制许可的E2F调节基因的关键转录激活因子。我们已经表明,c/eBP?依赖于DNA复制因子的诱导既受到TGF -A的刺激,又依赖于原发性肝细胞中的C/EBP。。最近的证据已经确定了代谢状态与细胞周期相关基因激活之间的重要联系,包括受E2F因子调节的基因。 We have discovered that the potential coactivator PGC-1a, previously implicated in the response to fasting, is rapidly induced following partial hepatictomy in a C/EBP¿ -dependent manner and is bound to the promoters of E2F regulated genes including several C/EBP¿ targets, suggesting that this coactivator is an important link between metabolic signals and hepatocyte proliferation.根据我们的实验室和其他人的数据,我们假设C/EBP课程是生长因子和肝细胞代谢信号的中心集成因子。在特定目标1中,我们将研究C/EBP¿磷酸化和C/EBP¿-E2F相互作用在肝细胞增殖过程中DNA许可蛋白调节的贡献。在特定的目标2中,我们将通过C/EBP€调查激活PGC-1A的机制。在特定目标3中,我们将分析PGC-1A在再生肝脏中肝细胞增殖中的功能作用。该赠款申请直接响应计划公告PA-06-231。 “发育生物学和肝脏的再生。”了解肝细胞增殖的基础机制将为疗法的发展提供信息,以增强肝脏的再生能力,并将阐明在肝细胞癌发生的早期阶段发生的异常肝细胞增殖机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda E GREENBAUM其他文献
Linda E GREENBAUM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda E GREENBAUM', 18)}}的其他基金
FASEB SRC on Liver Biology: Fundamental Mechanisms & Translational Application
FASEB SRC 肝脏生物学:基本机制
- 批准号:
8397455 - 财政年份:2012
- 资助金额:
$ 26.25万 - 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
- 批准号:
8265850 - 财政年份:2010
- 资助金额:
$ 26.25万 - 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
- 批准号:
8048131 - 财政年份:2010
- 资助金额:
$ 26.25万 - 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
- 批准号:
7863457 - 财政年份:2010
- 资助金额:
$ 26.25万 - 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
- 批准号:
8480398 - 财政年份:2010
- 资助金额:
$ 26.25万 - 项目类别:
Signaling pathways and the fate of hepatic progenitor cells
信号通路和肝祖细胞的命运
- 批准号:
8434170 - 财政年份:2010
- 资助金额:
$ 26.25万 - 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
- 批准号:
7848538 - 财政年份:2009
- 资助金额:
$ 26.25万 - 项目类别:
Transcriptional Control in Hepatocyte Proliferation
肝细胞增殖的转录控制
- 批准号:
6524459 - 财政年份:2001
- 资助金额:
$ 26.25万 - 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
- 批准号:
7800423 - 财政年份:2001
- 资助金额:
$ 26.25万 - 项目类别:
Transcriptional Control in Hepatocyte Proliferation
肝细胞增殖的转录控制
- 批准号:
6400608 - 财政年份:2001
- 资助金额:
$ 26.25万 - 项目类别:
相似国自然基金
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型腺病毒载体Ad49L介导的高水平干扰素α抑制疫苗体液免疫的机制
- 批准号:82302001
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
新型腺病毒载体疫苗长效免疫机制
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
新型腺病毒载体疫苗长效免疫机制
- 批准号:82271868
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
基于肠道腺病毒载体平台COVID-19粘膜疫苗的设计与筛选
- 批准号:82161138001
- 批准年份:2021
- 资助金额:150 万元
- 项目类别:国际(地区)合作与交流项目
相似海外基金
The Role of Peroxiredoxin 4 in Idiopathic Pulmonary Fibrosis
过氧化还原蛋白 4 在特发性肺纤维化中的作用
- 批准号:
10022135 - 财政年份:2019
- 资助金额:
$ 26.25万 - 项目类别:
Transcriptional control in hepatocyte proliferation
肝细胞增殖的转录控制
- 批准号:
7848538 - 财政年份:2009
- 资助金额:
$ 26.25万 - 项目类别:
Adenovirus vectored vaccines for Alzheimer's disease
用于阿尔茨海默病的腺病毒载体疫苗
- 批准号:
7221753 - 财政年份:2007
- 资助金额:
$ 26.25万 - 项目类别:
Adenoviral Vector-based Pandemic Influenza Vaccine
基于腺病毒载体的大流行性流感疫苗
- 批准号:
10618965 - 财政年份:2005
- 资助金额:
$ 26.25万 - 项目类别:
Adenoviral Vector-based Pandemic Influenza Vaccine
基于腺病毒载体的大流行性流感疫苗
- 批准号:
10467640 - 财政年份:2005
- 资助金额:
$ 26.25万 - 项目类别: